Literature DB >> 4633863

The use of clonazepam as an anticonvulsant--clinical evaluation.

P F Bladin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4633863

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  8 in total

1.  Letter: Clonazepam in the treatment of drug-induced dyskinesia.

Authors:  P M O'Flanagan
Journal:  Br Med J       Date:  1975-02-01

2.  Paradoxical reactions to benzodiazepines.

Authors:  R C Hall; S Zisook
Journal:  Br J Clin Pharmacol       Date:  1981       Impact factor: 4.335

3.  A major psychotomimetic complication of multidrug intravenous sedation.

Authors:  J T Jastak; F J Marshall
Journal:  Anesth Prog       Date:  1984 Sep-Oct

4.  Pharmacokinetics and side-effects of clonazepam and its 7-amino-metabolite in man.

Authors:  O Sjö; E F Hvidberg; J Naestoft; M Lund
Journal:  Eur J Clin Pharmacol       Date:  1975-04-04       Impact factor: 2.953

5.  Clonazepam: a review of its pharmacological properties and therapeutic efficacy in epilepsy.

Authors:  R M Pinder; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1976-11       Impact factor: 9.546

Review 6.  CNS adverse events associated with antiepileptic drugs.

Authors:  Gina M Kennedy; Samden D Lhatoo
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

7.  Plasma concentrations of clonazepam after single rectal administration.

Authors:  G W Rylance; J Poulton; R C Cherry; R E Cullen
Journal:  Arch Dis Child       Date:  1986-02       Impact factor: 3.791

Review 8.  Benzodiazepines in the Management of Seizures and Status Epilepticus: A Review of Routes of Delivery, Pharmacokinetics, Efficacy, and Tolerability.

Authors:  Adam Strzelczyk; Laurent M Willems; Ricardo Kienitz; Lara Kay; Isabelle Beuchat; Sarah Gelhard; Sophie von Brauchitsch; Catrin Mann; Alexandra Lucaciu; Jan-Hendrik Schäfer; Kai Siebenbrodt; Johann-Philipp Zöllner; Susanne Schubert-Bast; Felix Rosenow
Journal:  CNS Drugs       Date:  2022-08-16       Impact factor: 6.497

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.